References
- Bao Y, Wen T, Samia AC, et al. (2016). Magnetic nanoparticles: material engineering and emerging applications in lithography and biomedicine. J Mater Sci 51:513–53
- Beiranvand S, Eatemadi A, Karimi A. (2016). New updates pertaining to drug delivery of local anesthetics in particular bupivacaine using lipid nanoparticles. Nanoscale Res Lett 11:307
- Brule S, Levy M, Wilhelm C, et al. (2011). Doxorubicin release triggered by alginate embedded magnetic nanoheaters: a combined therapy. Adv Mater 23:787–90
- Bulucu F, Ocal R, Karadurmus N, et al. (2009). Effects of N-acetylcysteine, deferoxamine and selenium on doxorubicin-induced hepatotoxicity. Biol Trace Elem Res 132:184–96
- Chen FH, Gao Q, Ni JZ. (2008). The grafting and release behavior of doxorubincin from Fe3O4@SiO2 core-shell structure nanoparticles via an acid cleaving amide bond: the potential for magnetic targeting drug delivery. Nanotechnology 19:165103
- Chen SZ, Hao XH, Liang XJ, et al. (2016). Inorganic nanomaterials as carriers for drug delivery. J Biomed Nanotechnol 12:1–27
- Davis ME, Chen ZG, Shin DM. (2008). Nanoparticle therapeutics: an emerging treatment modality for cancer. Nat Rev Drug Discov 7:771–82
- DeMarino C, Schwab A, Pleet A, et al. (2016). Biodegradable nanoparticles for delivery of therapeutics in CNS infection. J Neuroimmune Pharmacol. doi:10.1007/s11481-016-9692-7
- Farokhzad OC, Langer R. (2009). Impact of nanotechnology on drug delivery. ACS Nano 3:16–20
- He X, Gao J, Gambhir SS, Cheng Z. (2010). Near-infrared fluorescent nanoprobes for cancer molecular imaging: status and challenges. Trends Mol Med 16:574–83
- Injac R, Strukej B. (2008). Recent advances in protection against doxorubicin-induced toxicity. Technol Cancer Res Treat 7:497–516
- Iqbal M, Dubey K, Anwer T, et al. (2008). Protective effects of telmisartan against acute doxorubicin-induced cardiotoxicity in rats. Pharmacol Rep 60:382–90
- Jeffrey SC, Nguyen MT, Andreyka JB, et al. (2006). Dipeptide-based highly potent doxorubicin antibody conjugates. Bioorg Med Chem Lett 16:358–62
- Jordan A, Maier-Hauff K, Wust P, Johannsen M. (2006) Nanoparticles for thermotherapy In: Nanomaterials for cancer therapy. Weinheim, Germany: VCH
- Liu H, Chen D, Li L, et al. (2011). Multifunctional gold nanoshells on silica nanorattles: a platform for the combination of photothermal therapy and chemotherapy with low systemic toxicity. Angew Chem Int Ed Engl 50:891–95
- Liu TY, Hu SH, Liu KH, et al. (2008). Study on controlled drug permeation of magnetic-sensitive ferrogels: effect of Fe3O4 and PVA. J Control Release 126:228–36
- Long NV, Yang Y, Teranishi T, et al. (2015). Biomedical applications of advanced multifunctional magnetic nanoparticles. J Nanosci Nanotechnol 15:10091–107
- McGill SL, Cuylear CL, Adolphi NL, et al. (2009). Magnetically responsive nanoparticles for drug delivery applications using low magnetic field strengths. Ieee Trans Nanobioscience 8:33–42
- Mohammed L, Ragab D, Gomaa H. (2016). Bioactivity of hybrid polymeric magnetic nanoparticles and their applications in drug delivery. Curr Pharm Des 22:3332–52
- Oliveira H, Perez-Andres E, Thevenot J, et al. (2013). Magnetic field triggered drug release from polymersomes for cancer therapeutics. J Control Release 169:165–70
- Satarkar NS, Hilt JZ. (2008). Magnetic hydrogel nanocomposites for remote controlled pulsatile drug release. J Control Release 130:246–51
- Soni G, Yadav KS. (2016). Nanogels as potential nanomedicine carrier for treatment of cancer: a mini review of the state of the art. Saudi Pharm J 24:133–39
- Yellepeddi VK, Ghandehari H. (2016). Poly(amido amine) dendrimers in oral delivery. Tissue Barriers 4:e1173773
- Zhao ZH, Huang DT, Yin ZY, et al. (2012). Magnetite nanoparticles as smart carriers to manipulate the cytotoxicity of anticancer drugs: magnetic control and pH-responsive release. J Mater Chem 22:15717–25